104 related articles for article (PubMed ID: 25303800)
1. Development of novel combined anticalcification protocols including immunologic modification for prolonged durability of cardiac xenograft: preclinical study using large-animal long-term circulatory models.
Lim HG; Jeong S; Shin JS; Park CG; Kim YJ
ASAIO J; 2015; 61(1):87-95. PubMed ID: 25303800
[TBL] [Abstract][Full Text] [Related]
2. Development of a next-generation tissue valve using a glutaraldehyde-fixed porcine aortic valve treated with decellularization, α-galactosidase, space filler, organic solvent and detoxification.
Lim HG; Kim GB; Jeong S; Kim YJ
Eur J Cardiothorac Surg; 2015 Jul; 48(1):104-13. PubMed ID: 25315752
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy for novel combined anticalcification treatment of glutaraldehyde-fixed cardiac xenograft using humanized mice.
Lim HG; Choi SY; Jeong S; Shin JS; Park CG; Kim YJ
J Biomater Appl; 2015 Feb; 29(7):929-40. PubMed ID: 25245780
[TBL] [Abstract][Full Text] [Related]
4. Anticalcification effect of a combination of decellularization, organic solvents and amino acid detoxification on glutaraldehyde-fixed xenopericardial heart valves in a large-animal long-term circulatory model.
Park CS; Kim YJ; Lee JR; Lim HG; Chang JE; Jeong S; Kwon N
Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):391-399. PubMed ID: 28505294
[TBL] [Abstract][Full Text] [Related]
5. Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium.
Lim HG; Kim SH; Choi SY; Kim YJ
Eur J Cardiothorac Surg; 2012 Feb; 41(2):383-90. PubMed ID: 21683607
[TBL] [Abstract][Full Text] [Related]
6. Immune response to bovine pericardium implanted into α1,3-galactosyltransferase knockout mice: feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts.
Lee C; Ahn H; Kim SH; Choi SY; Kim YJ
Eur J Cardiothorac Surg; 2012 Jul; 42(1):164-72. PubMed ID: 22223697
[TBL] [Abstract][Full Text] [Related]
7. The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse.
Sung Jeong W; Jin Kim Y; Lim HG; Jung S; Ryul Lee J
J Heart Valve Dis; 2016 Mar; 25(2):253-261. PubMed ID: 27989076
[TBL] [Abstract][Full Text] [Related]
8. Valved conduit with glutaraldehyde-fixed bovine pericardium treated by anticalcification protocol.
Lim HG; Kim GB; Jeong S; Kim YJ
Korean J Thorac Cardiovasc Surg; 2014 Aug; 47(4):333-43. PubMed ID: 25207241
[TBL] [Abstract][Full Text] [Related]
9. In vivo efficacy of alpha-galactosidase as possible promise for prolonged durability of bioprosthetic heart valve using alpha1,3-galactosyltransferase knockout mouse.
Lim HG; Choi SY; Yoon EJ; Kim SH; Kim YJ
Tissue Eng Part A; 2013 Nov; 19(21-22):2339-48. PubMed ID: 23672462
[TBL] [Abstract][Full Text] [Related]
10. High-concentration glutaraldehyde fixation of bovine pericardium in organic solvent and post-fixation glycine treatment: in vitro material assessment and in vivo anticalcification effect.
Lee C; Kim SH; Choi SH; Kim YJ
Eur J Cardiothorac Surg; 2011 Mar; 39(3):381-7. PubMed ID: 20739186
[TBL] [Abstract][Full Text] [Related]
11. Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model.
Pettenazzo E; Valente M; Thiene G
Eur J Cardiothorac Surg; 2008 Aug; 34(2):418-22. PubMed ID: 18550382
[TBL] [Abstract][Full Text] [Related]
12. Elimination of alpha-gal xenoreactive epitope: alpha-galactosidase treatment of porcine heart valves.
Choi SY; Jeong HJ; Lim HG; Park SS; Kim SH; Kim YJ
J Heart Valve Dis; 2012 May; 21(3):387-97. PubMed ID: 22808845
[TBL] [Abstract][Full Text] [Related]
13. Glutaraldehyde-fixed kangaroo aortic wall tissue: histology, crosslink stability and calcification potential.
Neethling WM; Hodge AJ; Glancy R
J Biomed Mater Res B Appl Biomater; 2003 Jul; 66(1):356-63. PubMed ID: 12808595
[TBL] [Abstract][Full Text] [Related]
14. Decellularization as an anticalcification method in stentless bovine pericardium valve prosthesis: a study in sheep.
Collatusso C; Roderjan JG; Vieira ED; Myague NI; Noronha Ld; Costa FD
Rev Bras Cir Cardiovasc; 2011; 26(3):419-26. PubMed ID: 22086579
[TBL] [Abstract][Full Text] [Related]
15. Durability of glutaraldehyde-fixed pericardial valve prostheses: clinical and animal experimental studies.
Valente M; Minarini M; Ius P; Talenti E; Bortolotti U; Milano A; Thiene G
J Heart Valve Dis; 1992 Nov; 1(2):216-24. PubMed ID: 1341632
[TBL] [Abstract][Full Text] [Related]
16. Immune response in patients receiving a bioprosthetic heart valve: lack of response with decellularized valves.
Bloch O; Golde P; Dohmen PM; Posner S; Konertz W; Erdbrügger W
Tissue Eng Part A; 2011 Oct; 17(19-20):2399-405. PubMed ID: 21557643
[TBL] [Abstract][Full Text] [Related]
17. Next-generation transcatheter aortic valve implantation.
Lim HG; Jeong S; Kim GB; Lee W; Son KH; Kim YJ
JTCVS Open; 2020 Sep; 3():14-24. PubMed ID: 36003870
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid grafting mitigates calcification of glutaraldehyde-fixed bovine pericardium.
Ohri R; Hahn SK; Hoffman AS; Stayton PS; Giachelli CM
J Biomed Mater Res A; 2004 Aug; 70(2):328-34. PubMed ID: 15227678
[TBL] [Abstract][Full Text] [Related]
19. Calcification of decellularized and alpha-galactosidase-treated bovine pericardial tissue in an alpha-Gal knock-out mouse implantation model: comparison with primate pericardial tissue.
Kim MS; Lim HG; Kim YJ
Eur J Cardiothorac Surg; 2016 Mar; 49(3):894-900. PubMed ID: 25994817
[TBL] [Abstract][Full Text] [Related]
20. Detoxification on top of enhanced, diamine-extended glutaraldehyde fixation significantly reduces bioprosthetic root calcification in the sheep model.
Trantina-Yates AE; Human P; Zilla P
J Heart Valve Dis; 2003 Jan; 12(1):93-100; discussion 100-1. PubMed ID: 12578343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
